Baim Institute for Clinical Research
Mayme Lou Roettig currently serves as the Senior Vice President for Strategic Initiatives and Business Development and Head of Strategic Partnerships & Development at Baim Institute for Clinical Research since February 2023. Prior experience includes roles as Executive Medical Director at PLx Pharma Inc. and Senior Director of Real World Evidence and Solutions at IQVIA. Mayme's extensive background also features leadership positions at Duke Clinical Research Institute, where responsibilities included Strategic Business Development and Operations Director for Health Systems and Services Research, and at the American Heart Association as National Director of Mission: Lifeline. Early career experience includes significant roles in nursing and cardiology at various hospitals, including Northwest Community Hospital and Providence Hospital Mobile. Mayme holds a Master of Science in Nursing from Loyola University Chicago and both a Bachelor of Science in Nursing and an Associate Degree in Nursing from the University of Charleston.
This person is not in any offices
Baim Institute for Clinical Research
Formerly known as the Harvard Clinical Research Institute, The Baim Institute for Clinical Research is a leading, not-for-profit academic research organization (ARO) that delivers insight, innovation and leadership in today's dynamic research environment. The Baim Institute collaborates with some of the world's most highly respected researchers from renowned institutions to help advance healthy and quality of life around the world. We combine the logistical capabilities of a contract research organization with world-class academic scientific leadership. We have a proven track record in designing and executing clinical studies. Since 1993, we have worked on over 450 clinical trials in North America, Europe and Asia. Dr. Donald Baim was a world-renowned pioneer in cardiovascular research. He dedicated his career to bringing innovative medical technologies forward, and cared deeply about the effective use of new therapeutics. He was an inspiration to generations of physician leaders for his ability to couple scientific thought with an unceasing commitment to improve patient care. He embodies the principles on which our Institute was founded and continues to grow.